Cathelicidin-BF

金环蛇抗菌肽

Report date: 2022/03/01 20:01:17
NME

Base Information

Drug NameCathelicidin-BF
Drug Alias NameCath-BFBF-30
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathelicidin antimicrobial peptide stimulants
TargetsCathelicidin antimicrobial peptide
Therapy Area/IndicationsVaginosis, Bacterial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Kanger Biomedicine Co LtdChina Pharmaceutical University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSuzhou Kanger Biomedicine Co LtdChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsVaginosis, Bacterial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A